Warman v. LivaNova Deutschland

2023 Ohio 4045, 228 N.E.3d 636
CourtOhio Court of Appeals
DecidedNovember 8, 2023
DocketC-230149, C-230150
StatusPublished

This text of 2023 Ohio 4045 (Warman v. LivaNova Deutschland) is published on Counsel Stack Legal Research, covering Ohio Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Warman v. LivaNova Deutschland, 2023 Ohio 4045, 228 N.E.3d 636 (Ohio Ct. App. 2023).

Opinion

[Cite as Warman v. LivaNova Deutschland, 2023-Ohio-4045.]

IN THE COURT OF APPEALS FIRST APPELLATE DISTRICT OF OHIO HAMILTON COUNTY, OHIO

DARREN WARMAN, : APPEAL NOS. C-230149 C-230150 Plaintiff-Appellant, : TRIAL NOS. A-2200202 A-2203770 vs. : O P I N I O N. LIVANOVA DEUTSCHLAND, GMBH, : f.k.a. SORIN GROUP DEUTSCHLAND, GMBH, :

LIVANOVA USA, INC., :

LIVANOVA HOLDING USA, INC., :

TRIHEALTH, INC., :

and :

GOOD SAMARITAN HOSPITAL OF : CINCINNATI, OHIO,

Defendants-Appellees. :

Civil Appeals From: Hamilton County Court of Common Pleas

Judgment Appealed From Is: Affirmed

Date of Judgment Entry on Appeal: November 8, 2023

Thomas Law Offices, PLLC, and Louis C. Schneider, for Plaintiff-Appellant,

Rendigs, Fry, Kiely & Dennis, LLP, and Brian Goldwasser, for Defendants-Appellees TriHealth, Inc., and Good Samaritan Hospital of Cincinnati, Ohio, OHIO FIRST DISTRICT COURT OF APPEALS

Faegre Drinker Biddle & Reath, LLP, M. Joseph Winebrenner, Nelson Mullins Riley & Scarborough, LLP, Zachary C. Maciaszek and Dustin B. Rawlin, for Defendants- Appellees LivaNova Deutschland GMBH, LivaNova USA, Inc., and LivaNova Holding USA, Inc.

2 OHIO FIRST DISTRICT COURT OF APPEALS

BERGERON, Presiding Judge.

{¶1} The overarching goal of Ohio’s discovery rules is to prevent unfair

surprise and concealment by facilitating the free flow of relevant information between

parties. However, courts have broad discretion to manage the scope of discovery to

ensure it remains “proportional to the needs of the case.” Civ.R. 26(B)(1).

Accordingly, when plaintiff-appellant Darren Warman proved unable to point to

anything in his own medical records to substantiate his claim of injury (allegedly

caused by defendant-appellee LivaNova’s medical device), the trial court acted within

its discretion to suspend discovery unless and until he could do so. The trial court

afforded him ample time and opportunity to procure relevant expert evidence, but he

mustered neither an opinion indicating that he actually suffered from the relevant

condition nor any indication that some missing discovery would enable his expert to

reach a diagnosis that would justify the lawsuit. On the limited facts in this record, the

trial court acted within its discretion in dismissing his claims for failure to comply with

its discovery order. We therefore affirm its judgment.

I.

{¶2} Mr. Warman underwent heart surgery in July 2015 at defendant-

appellee Good Samaritan Hospital in Cincinnati. In January 2020, he received a letter

from defendant-appellee TriHealth, Inc., notifying him that he may have been exposed

to harmful bacteria emitted from LivaNova’s Sorin Stockert 3T Heater-Cooler Device

(“3T System”), which regulates the patient’s blood temperature during heart surgeries.

The 3T System is the subject of a federal multidistrict litigation (“MDL”) centralized

in the United States District Court for the Western District of Pennsylvania. There,

plaintiffs typically allege that, due to design defects, the 3T System emits 3 OHIO FIRST DISTRICT COURT OF APPEALS

Nontuberculous Mycobacteria (“NTM”), a group of bacteria that includes

Mycobacterium (M.) chimaera, M. abscessus, and M. fortiuitum, among others. They

contend that they contract infections, sometimes years later, resulting from exposure

to aerosolized NTM emitted from the 3T System during heart surgeries. In total,

plaintiffs have brought more than 200 cases relating to NTM exposure from 3T

Systems in federal and state courts.

{¶3} Here, in multiple complaints, Mr. Warman claims he developed an

infection after exposure to M. chimaera emitted by the 3T System during his 2015

surgery. He first sued Good Samaritan Hospital and TriHealth, Inc., (collectively,

“hospital defendants”) in July 2021, claiming common law negligence. After

voluntarily dismissing that case without prejudice, he brought a separate complaint

against the hospital defendants (as “suppliers”) and multiple LivaNova entities

(together, “LivaNova”) (as the designer and manufacturer) for product liability claims

under R.C. 2307.71. LivaNova immediately removed the latter case to a federal court,

which then transferred it to the MDL court. The MDL court remanded the matter back

to the Hamilton County Court of Common Pleas for lack of subject matter jurisdiction.

Shortly thereafter, Mr. Warman refiled his negligence case against the hospital

defendants. After the bouncing procedural ball finally came to a rest, the trial court

consolidated the actions and issued a case management order (“CMO”) in September

2022, setting deadlines for discovery, expert reports, and summary judgment motions.

{¶4} That same month, after the remand, Mr. Warman asked defendants for

discovery. They balked, citing their pending motion to dismiss, and demanded some

proof that he had actually developed a post-operative infection and that it had some

causal connection to NTM emitted by the 3T System, as he claimed. Defendants

4 OHIO FIRST DISTRICT COURT OF APPEALS

turned to the trial court later that month, moving it to modify its CMO to include a

“tiered approach to discovery” under which the court would stay all discovery until Mr.

Warman could support his claims with an expert opinion. The record does not show

any initial discovery requests from either side, and we presume that none was served.

{¶5} In essence, defendants asked the court to impose a “Lone Pine” order.

Under such an order, the trial court typically requires plaintiffs, under penalty of

dismissal, to produce prima facie evidence of injury, exposure to the harmful

substance or device in question, and causation. See generally Nora Freeman

Engstrom, The Lessons of Lone Pine, 129 Yale L.J. 2 (2019). Though Lone Pine orders

are somewhat common in mass toxic-tort litigation and MDL cases, trial courts rarely

impose them in single-plaintiff cases (for a host of reasons that we need not explore

here).

{¶6} The trial court considered defendants’ motion at an October 2022

hearing. After first rejecting their motion to dismiss, the trial court entertained

argument from Mr. Warman and defendants regarding the status of discovery, Mr.

Warman’s medical records, and what, if any, information he needed in discovery from

defendants to establish the basis for his claims. Mr. Warman’s counsel objected to

defendants’ motion, arguing he was entitled to complete discovery, but assured the

court: “I’ve got all kinds of medical records that he’s got an infection. Do you want me

to have a doctor produce a report that my client got an infection as a result of the

surgery? I can do that.” Consistent with that admission, defendants argued that he

would have everything he needed—namely, his own medical records—to both establish

that he had some type of post-operative infection and that he had or has NTM in his

system. The trial court agreed with defendants and instructed Mr. Warman “to show

5 OHIO FIRST DISTRICT COURT OF APPEALS

me something that shows your client had this or currently has it” within 60 days,

referring either to the presence of NTM in Mr. Warman’s system or other evidence of

an NTM-related infection. It added, “You got to show he’s got it or you’re out.”

However, it held defendants’ motion in abeyance and made no definitive ruling

regarding a stay of discovery.

{¶7} Mr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In re Hirt
2026 Ohio 681 (Ohio Court of Appeals, 2026)

Cite This Page — Counsel Stack

Bluebook (online)
2023 Ohio 4045, 228 N.E.3d 636, Counsel Stack Legal Research, https://law.counselstack.com/opinion/warman-v-livanova-deutschland-ohioctapp-2023.